Groundbreaking advancements in the treatment of patients with advanced urothelial carcinoma
EVENT DETAILS
ACCREDITATION
Speakers: Normand Blais, Bernie Eigle & Srikala Sridhar
OBJECTIVES
By participating in this learning program, healthcare providers can expect to:
- Outline the evolution of treatment options for patients with advanced urothelial carcinoma.
- Review the newly introduced treatment option of IO+ADC in the advanced setting.
- Discuss the potential side effects and offer strategies to effectively manage the adverse events associated with novel therapies used in advanced urothelial carcinoma.